With more than 35 years of executive experience across agriculture, biomed, and logistics, Meltzer stepped into the CEO role at Nanox in 2022 with a track record of turning around complex organizations. At Netafim, he took charge at a time when the company faced stagnant sales and fragmented operations. In just three years, he restructured the business, restored growth, and set the foundation for its shift from selling products to delivering irrigation solutions. He later led Africa-Israel Investments, one of Israel’s largest holding companies, where he oversaw a $1.3 billion IPO on the London Stock Exchange in 2007—then the largest Israeli IPO to date.
Now at Nanox, Meltzer is applying that transformation mindset to healthcare. At the core of Nanox’s technology is a digital, cold-cathode X-ray source, which is more like a computer chip than a filament bulb. This innovation powers the Nanox Arc, a curved scanning device that captures 3D images and uses artificial intelligence to analyze them in real time.
But it’s the business model that truly sets Nanox apart. “People there have never been exposed to the ability to get medical imaging or proper healthcare,” Meltzer said of rural areas in Africa and Southeast Asia that the technology could reach. Additionally, the shift from expensive hardware purchases to usage-based pricing also opens the door for global deployment in underserved regions.
Meltzer has also overseen strategic acquisitions to support the model. Nanox now includes teleradiology firm USARAD, AI platform Nanox AI (formerly Zebra Medical), and MDW, which facilitates fast payments to interpreting radiologists. Together, these tools turn imaging into a cloud-enabled diagnostic network.
Meltzer wants to make predictive, preventive care the default. For him, the metric for success is ensuring that someone in a remote village can receive a timely diagnosis and only pay for what they use.
